Clinical trial
New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis
NCT00244179 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00244179 |
|---|---|
| Title | New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis |
| Official title | New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis: Immunostimulation Plus Antibiotic Versus Immunosuppression Plus Antibiotic Versus Conventional Standardtherapy |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | dfg |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Reactive Arthritis |
| Intervention type | Drug |
| Interventions | interferon-gamma, infliximab, dmard |
| Enrollment | 40 |
| Start date | Jan 1, 2003 |
| First posted | Oct 26, 2005 |
| Last update posted | Sep 8, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: